Anticoagulants for acute ischaemic stroke
23 results
1 - 23
Anticoagulants for acute ischaemic stroke
Anticoagulants for acute ischaemic stroke - Anticoagulants versus antiplatelet agents for acute ischaemic stroke: Cochrane systematic review
- Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
- Antithrombotic agents in primary health care
Early DOAC initiation after acute ischemic stroke reduces recurrent strokes without increasing risk of intracranial bleeds (CATALYST)- Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack
- Cerebral infarction (ischaemic stroke)
- In adults with atrial fibrillation and acute ischemic strokes, early (within 4 days) and delayed (7-10 days) initiation of DOACs have similar outcomes (OPTIMAS)
- Tongxinluo capsule for acute stroke
- Warfarin therapy
- Antiplatelet therapy for prevention of death, myocardial infarction, and stroke
- Intracerebral haemorrhage
- Acute coronary syndrome